There was no adverse effect after rituximab administration except for a transient severe leukopenia total neutrophil count of 132/mm3) in the first month, which was not complicated by clinical infection and was treated with prophylactic empiric antibiotics and granulocytic colony stimulating factor (G-CSF). Here, CSF3 is linked to Decreased total leukocyte count.